{"id":1215,"date":"2023-10-19T19:06:06","date_gmt":"2023-10-19T19:06:06","guid":{"rendered":"https:\/\/bcchrmicro.wpengine.com\/?page_id=1215"},"modified":"2026-11-06T22:26:21","modified_gmt":"2026-11-06T22:26:21","slug":"publications","status":"publish","type":"page","link":"https:\/\/www.bcchr.ca\/popi\/publications\/","title":{"rendered":"Publications"},"content":{"rendered":"<div  class=\"fndry-container fndry-responsive-bg fndry-responsive-border fndry-container--full fndry-pt--md-3 fndry-pr--md-3 fndry-pl--md-3 fndry-pb--md-6 fndry-pr--sm-2 fndry-pl--sm-2 fndry-pb--sm-3\" style=\"--fndry-bg:var(--fndry-color-tertiaryLight)\">\n\t<div  class=\"fndry-container fndry-responsive-bg fndry-responsive-border\">\n\t<div class=\"fndry-row fndry-align--center fndry-justify--sm-center fndry-justify--between\">\n\t<div  class=\"fndry-col fndry-responsive-bg fndry-col--6 fndry-col--md-10 fndry-col--sm-12 fndry-pl--2 fndry-pb--5 fndry-pt--5 fndry-pt--md-2 fndry-pb--md-2 fndry-pr--md-0 fndry-pl--md-0\">\n\t<div class=\"breadcrumbs align fndry-pb--2 wp-block-bcn-breadcrumb-trail has-text-color has-background\" vocab=\"https:\/\/schema.org\/\" typeof=\"BreadcrumbList\">\n\t<span><\/span>\n\t<span property=\"itemListElement\" typeof=\"ListItem\"><a property=\"item\" typeof=\"WebPage\" title=\"Go to Pharmaceutical Outcomes &amp; Policy Innovations.\" href=\"https:\/\/www.bcchr.ca\/popi\" class=\"home\" aria-current=\"page\"><span property=\"name\">Pharmaceutical Outcomes &amp; Policy Innovations<\/span><\/a><meta property=\"position\" content=\"1\"><\/span><\/div>\n<h1 class=\"fndry-heading\">Publications<\/h1><p class=\"fndry-paragraph fndry-text-bannerIntro20\">Explore POPi&#8217;s published research in pediatric medication safety and pharmacogenomics.<\/p><\/div>\n<div  class=\"fndry-col fndry-responsive-bg fndry-col--5 fndry-col--md-12\">\n\t<figure  class=\"fndry-image\" style=\"--imageWidth:100%;--img-height-all:100%\" aria-labelledby=\"img-2774\">\n\t<img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"425\" src=\"https:\/\/www.bcchr.ca\/popi\/files\/2026\/07\/publications-1.jpg\" class=\"fndry-image__img\" aria-hidden=\"true\" role=\"presentation\" style=\"--borderRadius:0px;--objectFit:cover;--imagePosX:50%;--imagePosY:50%\" srcset=\"https:\/\/www.bcchr.ca\/popi\/files\/2026\/07\/publications-1.jpg 500w, https:\/\/www.bcchr.ca\/popi\/files\/2026\/07\/publications-1-300x255.jpg 300w\" sizes=\"(max-width: 500px) 100vw, 500px\" \/><\/figure>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n<div  class=\"fndry-container fndry-responsive-bg fndry-responsive-border fndry-pt--5 fndry-pb--5 fndry-pr--md-1 fndry-pl--md-1 fndry-pt--md-3 fndry-pb--md-3 fndry-pt--sm-0 fndry-pb--sm-0 fndry-mt--sm-3 fndry-mb--sm-3\">\n\t<div class=\"fndry-row fndry-justify--center\">\n\t<div  class=\"fndry-col fndry-responsive-bg fndry-col--10 fndry-col--sm-12 fndry-col--md-12 fndry-pr--sm-2 fndry-pl--sm-2 fndry-pt--md-4 fndry-pb--md-4 fndry-pr--md-3 fndry-pl--md-3 fndry-d--flex fndry-flex--col fndry-align--start fndry-justify--center\">\n\t<h2 class=\"fndry-heading\" style=\"color:var(--fndry-color-secondary)\">Publications List<\/h2><ul  class=\"fndry-list fndry-d--flex fndry-flex--col\" style=\"--fndry-list-marker-color:var(--fndry-color-primary);--gap:20px\"><li\n\t class=\"fndry-list-item\">\n\tLoucks C, Groeneweg G, Roy C, Lee DK, Rieder MJ, Lebel D, Ito S, Ross CJ, Carleton BC.\u00a0<strong>Pharmacogenomic testing: the key to enhancing personalized medication use for patients<\/strong>. Can Fam Physician. 2020 Apr;66(4):241-243. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32273406\/\" target=\"_blank\" rel=\"noreferrer noopener\">32273406<\/a>\u00a0<\/li>\n<li\n\t class=\"fndry-list-item\">\n\tTakeuchi M, Kobayashi T, Biss T, Kamali F, Vear SI, Ho RH, Bajolle F, Loriot MA, Shaw K, Carleton BC, Hamberg AK, Wadelius M, Hirono K, Taguchi M, Wakamiya T, Yanagimachi M, Hirai K, Itoh K, Brand\u00e3o LR, Ito S.\u00a0<strong>CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis<\/strong>. Pharmacogenomics J. 2020 Apr;20(2):306-319. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31673144\/\" target=\"_blank\" rel=\"noreferrer noopener\">31673144<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tChang W, Abe R, Anderson P, Anderson W, Ardern-Jones MR, Beachkofsky TM, Bell\u00f3n T, Biala AK, Bouchard C, Cavalleri GL, Chapman N, Chodosh J, Choi HK, Cibotti RR, Divito SJ, Dewar K, Dehaeck U, Etminan M, Forbes D, Fuchs E, Goldman JL, Holmes JH, Hope EA, Hung S, Hsieh C, Iovieno A, Jagdeo J, Kim MK, Koelle DM, Lacouture ME, Le Pallec S, Lehloenya RJ, Lim R, Lowe A, McCawley J, McCawley J, Micheletti RG, Mockenhaupt M, Niemeyer K, Norcross MA, Oboh D, Olteanu C, Pasieka HB, Peter J, Pirmohamed M, Rieder M, Saeed HN, Shear NH, Shieh C, Straus S, Sukasem C, Sung C, Trubiano JA, Tsou S, Ueta M, Volpi S, Wan C, Wang H, Wang Z, Weintraub J, Whale C, Wheatley LM, Whyte-Croasdaile S, Williams KB, Wright G, Yeung SN, Zhou L, Chung W, Phillips EJ, Carleton BC.\u00a0<strong>SJS\/TEN 2019: From Science to Translation<\/strong>. J Dermatol Sci. 2020 Mar 7:S0923-1811(20)30064-5. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32192826\/\" target=\"_blank\" rel=\"noreferrer noopener\">32192826<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tNama N, Barker MK, Kwan C, Sabarre C, Solimano V, Rankin A, Raabe J, Ross CJ, Carleton B, Zwicker JG, Rassekh SR.\u00a0<strong>Vincristine-induced peripheral neurotoxicity: A prospective cohort<\/strong>. Pediatr Hematol Oncol. 2020 Feb;37(1):15-28. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31682156\/\" target=\"_blank\" rel=\"noreferrer noopener\">31682156<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tLasky T, Carleton B, Horton DB, Kelly LE, Bennett D, Czaja AS, Gifkins D, Osokogu OU, McMahon AW. \u00a0<strong>Real-world Evidence to Assess Medication Safety and Effectiveness in Children: Systematic Review<\/strong>. Drugs Real World Outcomes, 2020 Feb 28. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32112359\/\" target=\"_blank\" rel=\"noreferrer noopener\">32112359<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tMcMahon AW, Cooper WO, Brown JS, Carleton B, Doshi-Velez F, Kohane I, Goldman JL, Hoffman MA, Kamaleswaran R, Sakiyama M, Sekine S, Sturkenboom MC, Turner MA, Califf RM.\u00a0<strong>Big Data in the Assessment of Pediatric Medication Safety<\/strong>. Pediatrics. 2020 Feb;145(2):e20190562. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31937606\/\" target=\"_blank\" rel=\"noreferrer noopener\">31937606<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tKing C, McKenna A, Farzan N, Vijverberg S, van der Schee M, Maitland-van der Zee A, Arianto L, Bisgaard H, B\u00d8nnelykke K, Berce V, Poto\u010cnik U, Repnik K, Carleton B, Daley D, Chew FT, Chiang W, Sio YY, Cloutier M, Den Dekker H, Duijts L, de Jongste JC, Dijk FN, Flores C, Hernandez-Pacheco N, Mukhopadhyay S, Basu K, Bignell L, Tantisira K, Verhamme K, Celedon J, Forno E, Canino G, Francis B, Pirmohamed M, Sinha I, Hawcutt D.\u00a0<strong>Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization<\/strong>. Pharmacogenomics J. 2020 Jan 17. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31949291\/\" target=\"_blank\" rel=\"noreferrer noopener\">31949291<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Guo MY, Carleton B.\u00a0<strong>Comparison of Valvulopathy Risk with Lorcaserin and Phentermine-Topiramate for Weight Loss<\/strong>. Curr Drug Ther. 2019;14(1):74-78.\u00a0DOI:\u00a0<a href=\"https:\/\/www.eurekaselect.com\/161823\/article\" target=\"_blank\" rel=\"noreferrer noopener\">10.2174\/1574885513666180503141557<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Sodhi M, Sheldon CA, Carleton B.\u00a0<strong>Risk of Pseudotumor Cerebri Syndrome (PTCS) with Hormonal Contraceptive Use<\/strong>. Int J Reprod Contracept Gynecol. 2019;7(3):779.\u00a0DOI:\u00a0<a href=\"https:\/\/www.ijrcog.org\/index.php\/ijrcog\/article\/view\/4361\" target=\"_blank\" rel=\"noreferrer noopener\">10.18203\/2320-1770.ijrcog20180854<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tSodhi M, Etminan M, Carleton B, Samii A.\u00a0<strong>Risk of Pathological Gambling and Impulse Control Disorders With Dopamine Agonists: A Retrospective Cohort Study<\/strong>. J Clin Psychopharmacol. 2019 Nov\/Dec;39(6):675-676. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31688453\/\" target=\"_blank\" rel=\"noreferrer noopener\">31688453\u00a0<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tWright G, Dr\u00f6gem\u00f6ller B, Ross CJD, Carleton B.\u00a0<strong>Genome-wide association studies of drug induced liver injury make progress beyond the HLA region\u00a0<\/strong>(Letter to the Editor). Gastroenterology. 2019 Oct;157(4):1167-1168. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31348928\/\" target=\"_blank\" rel=\"noreferrer noopener\">31348928\u00a0<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Sodhi M, Ganjizadeh-Zavareh S, Carleton B, Kezouh A, Brophy JM.\u00a0<strong>Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation<\/strong>. J Am Coll Cardiol. 2019 Sep;74(11):1444-1450. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31514945\/\" target=\"_blank\" rel=\"noreferrer noopener\">31514945<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tBrowne M, Zakrzewski H, Carleton B, Etminan M, Mikelberg FS.\u00a0<strong>Association of Gabapentin or Pregabalin use and Incidence of Acute Angle-closure Glaucoma<\/strong>. J Glaucoma. 2019 Sep;28(9):777\u2013779. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31335554\/\" target=\"_blank\" rel=\"noreferrer noopener\">31335554<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tDr\u00f6gem\u00f6ller BI, Wright GEB, Lo C, Le T, Brooks B, Bhavsar AP, Rassekh SR, Ross CJD, Carleton BC.\u00a0<strong>Pharmacogenomics of Cisplatin-Induced Ototoxicity: Successes, Shortcomings and Future Avenues of Research<\/strong>. Clin Pharm Ther. 2019 Aug;106(2):350-359 PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31012503\/\" target=\"_blank\" rel=\"noreferrer noopener\">31012503<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tDe \u00c1vila Machado MA, de Moura CS, Klein M, Winthrop K, Carleton B, Abrahamowicz M, Feld J, Curtis JR, Beauchamp ME, Bernatsky S.\u00a0<strong>Direct-Acting Antivirals for Hepatitis C: Predictors of Early Discontinuation in the Real World<\/strong>. J Manag Care Spec Pharm. 2019 Jun;25(6):697-704. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31134863\/\" target=\"_blank\" rel=\"noreferrer noopener\">31134863<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tTanoshima R, Carleton BC.\u00a0<strong>The Incidence of Symptomatic Osteonecrosis After Allogeneic Haematopoietic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukaemia \u2013 Controversy on Dexamethasone as a Risk Factor<\/strong>\u00a0(Letter to the Editor). Br J Haematol. 2019 Jun;185(5):958-959. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30408145\/\" target=\"_blank\" rel=\"noreferrer noopener\">30408145<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Sodhi M, Samii A, Carleton B, Kezouh A, Avina-Zubieta JA.\u00a0<strong>Tumor Necrosis Factor Inhibitors and Risk of Peripheral Neuropathy in Patients with Rheumatic Diseases<\/strong>. Semin Arthritis Rheum. 2019 Jun;48(6): 1083-1086. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30337056\/\" target=\"_blank\" rel=\"noreferrer noopener\">30337056<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tZazuli Z, Otten LS, Dr\u00f6gem\u00f6ller BI, Medeiros M, Monzon JG, Wright GEB, Kollmannsberger CK, Bedard PL, Chen Z, Gelmon KA, McGoldrick N, Kitchlu A, Vijverberg SJH, Masereeuw R, Ross CJD, Liu G, Carleton BC, Maitland-van der Zee AH.\u00a0<strong>Outcome Definition Influences the Relationship Between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients<\/strong>. Genes. 2019 May;10(5):364. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31083486\/\" target=\"_blank\" rel=\"noreferrer noopener\">31083486<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tHe B, Carleton B, Etminan M.\u00a0<strong>Drs. He et al. reply to Drs. Lai and Brown<\/strong>. Pharmacotherapy. 2019 Jul;39(7):792-793. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31071231\/\" target=\"_blank\" rel=\"noreferrer noopener\">31071231<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tHe B, Carleton B, Etminan M.\u00a0<strong>Risk of Gynecomastia with Users of Proton Pump Inhibitors<\/strong>. \u00a0Pharmacotherapy 2019 May;39(5):614-618. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30865318\/\" target=\"_blank\" rel=\"noreferrer noopener\">30865318<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tTanoshima R, Khan A, Biala AK, Trueman JN, Dr\u00f6gem\u00f6ller BI, Wright GEB, Hasbullah JS, Groeneweg GSS, Ross CJD, Carleton BC.\u00a0<strong>Analyses of Adverse Drug Reactions Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety (CPNDS) database<\/strong>. J Clin Pharmacol. 2019 Mar;59(3):356-363. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30452777\/\" target=\"_blank\" rel=\"noreferrer noopener\">30452777<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tClemens E, Meijer AJM, Broer L, Langer T, van der Kooi ALF, Uitterlinden AG, Kuehni C, Luisagarre M, Tomas K, Kruseova J, Winther JF, Kremer LCM, van Dulmen-den Broeder E, Tissing WJE, Grabow D, Binder H, Kaatsch P, Zehnhoff AM, Carleton B, Zolk O, van den Heuvel-Eibrink MM.\u00a0<strong>Genetic Determinants of Ototoxicity during and after Childhood Cancer Treatment: Protocol for the PanCareLIFE study<\/strong>. \u00a0JMIR Res Protoc. 2019 Mar 19;8(3):e11868. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30888333\/\" target=\"_blank\" rel=\"noreferrer noopener\">30888333<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tMcLaughlin M, Wagner J, Shakhnovich V, Carleton B, Leeder J.\u00a0<strong>Considerations for Implementing Precision Therapeutics for Children<\/strong>. Clin Transl Sci. 2019 Mar;12(2):140-150. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30516322\/\" target=\"_blank\" rel=\"noreferrer noopener\">30516322<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Guo M, Carleton B.\u00a0<strong>Oral Fluoroquinolone Prescribing to Children in the United States from 2006 to 2015<\/strong>. Pediatr Infect Dis J. 2019 Mar;38(3):268-270. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29846302\/\" target=\"_blank\" rel=\"noreferrer noopener\">29846302<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tClemens E, Brooks B, de Vries ACH, van Grotel M, van den Heuvel-Eibrink M, Carleton B.\u00a0<strong>A Comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAE v4.03 Ototoxicity Grading Scales Applied to 3,799 Audiograms of Childhood Cancer Patients Treated with Platinum-Based Chemotherapy<\/strong>. PLOS ONE. 2019 Feb 14;14(2):e0210646. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30763334\/\" target=\"_blank\" rel=\"noreferrer noopener\">30763334<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tDr\u00f6gem\u00f6ller BI, Wright GEB, Shih J, Monzon J, Gelmon KA, Ross CJD, Amstutz U, Carleton BC on behalf of the CPNDS Clinical Recommendations Group.\u00a0<strong>CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines<\/strong>. Breast Cancer Res Treat. 2019 Feb;173(3):521-532. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30411242\/\" target=\"_blank\" rel=\"noreferrer noopener\">30411242<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tWright GEB, Amstutz U, Dr\u00f6gem\u00f6ller BI, Shih J, Rassekh SR, Hayden MR, Carleton BC, Ross CJD, the Canadian Pharmacogenomics Network for Drug Safety Consortium.\u00a0<strong>Pharmacogenomics of vincristine-induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes<\/strong>. Clin Pharmacol Ther. 2019 Feb;105(2):402-410. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29999516\/\" target=\"_blank\" rel=\"noreferrer noopener\">29999516<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tChau CMY, Ross CJD, Chau V, Synnes AR, Miller SP, Carleton BC, Grunau RE.\u00a0<strong>Morphine Biotransformation Genes and Neonatal Clinical Factors Predicted Behaviour Problems in Very Preterm Children at 18 Months<\/strong>. EBioMedicine. 2019 Feb;40:655-662. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30709768\/\" target=\"_blank\" rel=\"noreferrer noopener\">30709768<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tClemens E, van den Heuvel-Eibrink MM, Mulder RL, Kremer LCM, Hudson MM, Skinner R, Constine LS, Bass JK, Kuehni CE, Langer T, van Dalen EC, Bardi E, Bonne NX, Brock PR, Brooks B, Carleton B, Caron E, Chang KW, Johnston K, Knight K, Nathan PC, Orgel E, Prasad PK, Rottenberg J, Scheinemann K, de Vries ACH, Walwyn T, Weiss A, Am Zehnhoff-Dinnesen A, Cohn RJ, Landier W; International Guideline Harmonization Group ototoxicity group.\u00a0<strong>Recommendations for Ototoxicity Surveillance for Childhood, Adolescent, and Young Adult Cancer Survivors: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.\u00a0<\/strong>Lancet Oncol. 2019 Jan;20(1):e29-e41. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30614474\/\" target=\"_blank\" rel=\"noreferrer noopener\">30614474<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tGanjizadeh-Zavareh S, Sodhi M, Spangehl T, Carleton B, Etminan M.\u00a0<strong>Oral Fluoroquinolones and Risk of Fibromyalgia<\/strong>. Br J Clin Pharmacol. 2019 Jan;85(1):236-239. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30216492\/\" target=\"_blank\" rel=\"noreferrer noopener\">30216492<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tMansouri M, Yuan B, Ross CJD, Carleton BC, Ester M.\u00a0<strong>HUME: Large-scale Detection of Causal Genetic Factors of Adverse Drug Reactions<\/strong>. Bioinformatics. 2018 Dec 15;34(24):4274-4283. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29931042\/\" target=\"_blank\" rel=\"noreferrer noopener\">29931042<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tWendel C, Zakrzewski H, Carleton B, Etminan M, Mikelberg FS.\u00a0<strong>In Reply to Controversies on the Use of Glaucoma Medications During Surgery<\/strong>. J Glaucoma. 2018 Dec;27(12):e195-e196. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30180014\/\" target=\"_blank\" rel=\"noreferrer noopener\">30180014<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tDodd CN, de Ridder M, Huang W, Weibel D, Giner-Soriano M, Perez-Vilar S, Diez-Domingo J, Swenson LW, Mahmud SM, Carleton BC, Naus M, Kwong JC, Murray B, Arnheim-Dahlstrom L, Pederson L, Morros R, Puertas FJ, Black S, Sturkenboom M.\u00a0<strong>Incidence rates of narcolepsy diagnoses in Taiwan, Canada and Europe: the use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study<\/strong>. PLoS ONE. 2018 Oct 17;13(10):e0204799. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30332477\/\" target=\"_blank\" rel=\"noreferrer noopener\">30332477<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tSkeldon SC, Carleton B, Brophy JM, Sodhi M, Etminan M.\u00a0<strong>Statin Medications and the Risk of Gynecomastia<\/strong>. Clin Endocrinol (Oxf). 2018 Oct;89(4):470-473. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29923212\/\" target=\"_blank\" rel=\"noreferrer noopener\">29923212<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tWeibel D, Sturkenboom M, Black S, de Ridder M, Dodd C, Bonhoeffer J, Vanrolleghem A, van der Maas N, Lammers GJ, Overeem S, Gentile A, Giglio N, Castellano V, Kwong JC, Murray BJ, Cauch-Dudek K, Juhasz D, Compitelli M, Datta AN, Kallweit U, Huang W, Huang Y, Hsu C, Chen H, Giner-Soriano M, Morros R, Gaig C, Tio E, Perez-Vilar S, Diez-Domingo J, Puertas FJ, Svenson LW, Mahmud SM, Carleton B, Naus M, Arnheim-Dahlstr\u00f6m L, Pedersen L, DeStefano F, Shimabukuro TT.\u00a0<strong>Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines \u2013 Multi-country assessment<\/strong>. Vaccine. 2018 Oct;36(41):6202-6211. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30122647\/\" target=\"_blank\" rel=\"noreferrer noopener\">30122647<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tZazuli Z, Vijverberg S, Slob E, Liu G, Carleton B, Veltman J, Baas P, Masereeuw R, Maitland-van Der Zee AH.\u00a0<strong>Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review<\/strong>. Front. Pharmacol. 2018 Sep 27; 9:1111. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30319427\/\" target=\"_blank\" rel=\"noreferrer noopener\">30319427<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tScott E, Hasbullah JS, Ross CJD, Carleton BC.\u00a0<strong>Reducing anthracycline-induced cardiotoxicity through pharmacogenetics<\/strong>. Pharmacogenomics. 2018 Oct;19(15):1147-1150. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30213233\/\" target=\"_blank\" rel=\"noreferrer noopener\">30213233<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tKim DD, Barr AM, Chung Y, Yuen JWY, Etminan M, Carleton BC, White RF, Honer WG, Procyshyn RM.\u00a0<strong>Antipsychotic-Associated Symptoms of Tourette Syndrome: A Systematic Review<\/strong>. CNS Drugs. 2018 Oct;32(10):917-938. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30121819\/\" target=\"_blank\" rel=\"noreferrer noopener\">30121819<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tLiu RT, Yeung SN, Carleton B, Etminan M.\u00a0<strong>Risk of Anterior Segment Complications Associated with the Live Herpes Zoster Vaccine: Evidence from a Health-Claim Database<\/strong>. Cornea. 2018 Aug;37(8):952-956. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29601366\/\" target=\"_blank\" rel=\"noreferrer noopener\">29601366<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tGuo MY, Etminan M, Procyshyn RM, Kim DD, Samii A, Kezouh A, Carleton BC.\u00a0<strong>Association of Antidepressant Use with Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiologicsal Study<\/strong>. J Clin Psychopharmacol. 2018 Aug;38(4):349-356. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29901567\/\" target=\"_blank\" rel=\"noreferrer noopener\">29901567<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tKowalec K, Wright GEB, Dr\u00f6gem\u00f6ller BI, Aminkeng F, Bhavsar AP, Kingwell E, Yoshida EM, Traboulsee A, Marrie RA, Kremenchutzky M, Campbell TL, Duquette P, Chalasani N, Wadelius M, Hallberg P, Xia Z, De Jager PL, Denny JC, Davis MF, Ross CJD, Tremlett H, Carleton BC.\u00a0<strong>Common variation near IRF6 is associated with IFN-\u03b2-induced liver injury in multiple sclerosis<\/strong>. Nat Genet. 2018 Aug;50(8):1081-1085. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30013178\/\" target=\"_blank\" rel=\"noreferrer noopener\">30013178<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tvon Dadelszen P, Magee LA, Benton SJ, Hu Y, Ansermino JM, Carleton B, Carter C, Douglas MJ, Janssen PA, Lee SK, Leung PCK, Li J, MacNab Y, Payne BA, Peng G, Rodger M, Skoll MA, Synnes A, Walley KR, Russell JA.\u00a0<strong>Activated protein C as disease-modifying therapy in antenatal preeclampsia: An open-label, single arm safety and efficacy trial<\/strong>. Pregnancy Hypertens. 2018 Jul;13:121-126. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30177038\/\" target=\"_blank\" rel=\"noreferrer noopener\">30177038<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tClemens E, van der Kooi ALF, Broer L, van Dulmen-den Broeder E, Visscher H, Kremer L, Tissing W, Loonen J, Ronckers CM, Pluijm SMF, Neggers SJCMM, Zolk O, Langer T, am Zehnhoff-Dinnesen, Wilson CL, Hudson MM, Carleton B, Laven JSE, Uitterlinden AG, van den Heuvel-Eibrink MM.\u00a0<strong>The Influence of Genetic Variation on Late Toxicities in Childhood Cancer Survivors: A Review<\/strong>. Crit Rev Oncol Hematol. 2018 June;126:154-167. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29759558\/\" target=\"_blank\" rel=\"noreferrer noopener\">29759558<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tSmy L, Shaw K, Amstutz U, Staub M, Chaudhry S, Smith A, Carleton B, Koren G.\u00a0<strong>Assessment of Hair Cortisol as a Potential Biomarker for Possible Adrenal Suppression due to Inhaled Corticosteroid Use in Children with Asthma: A Retrospective Observational Study<\/strong>. Clin Biochem. 2018 Jun;56:26-32. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29673814\/\" target=\"_blank\" rel=\"noreferrer noopener\">29673814<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tSmith N, Wang A, Shaw K, Groeneweg G, Goldman RD, Wilkinson B, Jimenez R, Mwai L, Carleton B.\u00a0<strong>Response to The Routine Use of Oral Steroids in Paediatric Asthma is Not Routine<\/strong>. Paediatr Child Health. 2018 May;23(3):239. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29769812\/\" target=\"_blank\" rel=\"noreferrer noopener\">29769812<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tWendel C, Zakrzewski H, Carleton B, Etminan M, Mikelberg FS.\u00a0<strong>Association of Postoperative Topical Prostaglandin Analog or Beta-blocker Use and Incidence of Pseudophakic Cystoid Macular Edema<\/strong>. J Glaucoma. 2018 May;27(5):402-406. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29505438\/\" target=\"_blank\" rel=\"noreferrer noopener\">29505438<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tDr\u00f6gem\u00f6ller B, Brooks B, Monzon JG, Wright GEB, Liu G, Renouf DJ, Kollmannsberger C, Bedard P, Hayden MR, Gelmon K, Carleton B, Ross CJD.\u00a0<strong>Further investigation of the role of ACYP2 and WFS1 pharmacogenomic variants in the development of cisplatin-induced ototoxicity in testicular cancer patients<\/strong>. Clin Cancer Res. 2018 Apr 15;24(8):1866-1871. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29358504\/\" target=\"_blank\" rel=\"noreferrer noopener\">29358504<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tPhillips E, Sukasem C, Whirl-Carrillo M, M\u00fcller D, Dunnenberger H, Chantratita W, Goldspiel B, Chen YT, Carleton BC, George A, Mushiroda T, Klein T, Gammal R, Pirmohamed M.\u00a0<strong>Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update<\/strong>. Clin Pharmacol Ther. 2018 Apr;103(4):574-581. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29392710\/\" target=\"_blank\" rel=\"noreferrer noopener\">29392710<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tMcLaughlin MJ, He Y, Brunstrom-Hernandez J, Thio LL, Carleton BC, Ross CJD, Gaedigk A, Lewandowski A, Dai H, Jusko WJ, Leeder JS.\u00a0<strong>Pharmacogenomic Variability of Oral Baclofen Clearance and Clinical Response in Children with Cerebral Palsy<\/strong>. PM R. 2018 Mar;10(3):235-243. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28867665\/\" target=\"_blank\" rel=\"noreferrer noopener\">28867665<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tDionne F, Aminkeng F, Bhavsar A, Groeneweg G, Smith A, Visscher H, Ross CRJ, Carleton BC.\u00a0<strong>An Initial Health Economic Evaluation of Pharmacogenomic testing in Patients treated for Childhood Cancer with Anthracyclines<\/strong>. Pediatric Blood Cancer. 2018 Mar;65(3). PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29271558\/\" target=\"_blank\" rel=\"noreferrer noopener\">29271558<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tSodhi M, Sheldon CA, Carleton B, Etminan M.\u00a0<strong>Risk of Pseudotumor Cerebri Syndrome (PTCS) with hormonal contraceptive use<\/strong>. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):778-782.\u00a0DOI:\u00a0<a href=\"https:\/\/www.ijrcog.org\/index.php\/ijrcog\/article\/view\/4361\" target=\"_blank\" rel=\"noreferrer noopener\">10.18203\/2320-1770.ijrcog20180854<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tWhite KD, Abe R, Ardern-Jones M, Beachkofsky T, Bouchard C, Carleton B, Chodosh J, Cibotti R, Davis R, Denny JC, Dodiuk-Gad RP, Ergen EN, Goldman JL, Holmes JH 4th, Hung SI, Lacouture ME, Lehloenya RJ, Mallal S, Manolio TA, Micheletti RG, Mitchell CM, Mockenhaupt M, Ostrov DA, Pavlos R, Pirmohamed M, Pope E, Redwood A, Rosenbach M, Rosenblum MD, Roujeau JC, Saavedra AP, Saeed HN, Struewing JP, Sueki H, Sukasem C, Sung C, Trubiano JA, Weintraub J, Wheatley LM, Williams KB, Worley B, Chung WH, Shear NH, Phillips EJ.\u00a0<strong>SJS \/TEN 2017: Building Multidisiplinary Networks to Drive Science and Translation<\/strong>. J Allergy Clin Immunol Pract. 2018 Jan &#8211; Feb;6(1):38-69. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29310768\/\" target=\"_blank\" rel=\"noreferrer noopener\">29310768<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Sodhi M, Procyshyn R, Guo M, Carleton B.\u00a0<strong>Risk of Hair Loss with Different Antidepressants: A Comparative Retrospective Cohort Study<\/strong>. Intl Clin Psychopharmacol. 2018 Jan;33(1):44-48. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28763345\/\" target=\"_blank\" rel=\"noreferrer noopener\">28763345<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tMcCormack M, Gui H, Ingason A, Speed D, Wright GEB, Zhang EJ, Secolin R, Yasuda C, Kwok M, Wolking S, Becker F, Rau S, Avbersek A, Heggeli K, Leu C, Depondt C, Sills GJ, Marson AG, Auce P, Brodie MJ, Francis B, Johnson MR, Koeleman BPC, Striano P, Coppola A, Zara F, Kunz WS, Sander JW, Lerche H, Klein KM, Weckhuysen S, Krenn M, Gudmundsson LJ, Stef\u00e1nsson K, Krause R, Shear N, Ross CJD, Delanty N; EPIGEN Consortium; Pirmohamed M, Carleton BC; Canadian Pharmacogenomics Network for Drug Safety; Cendes F, Lopes-Cendes I, Liao WP, O&#8217;Brien TJ, Sisodiya SM; EpiPGX Consortium; Cherny S, Kwan P, Baum L; International League Against Epilepsy Consortium on Complex Epilepsies; Cavalleri GL.\u00a0<strong>Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients<\/strong>. Neurology. 2018 Jan 23;90(4):e332-e341. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29288229\/\" target=\"_blank\" rel=\"noreferrer noopener\">29288229<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tWright G, Carleton B, Hayden M, Ross C.\u00a0<strong>The global spectrum of protein-coding pharmacogenomics diversity<\/strong>. Pharmacogenomics J. 2018 Jan;18(1):187-195. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27779249\/\" target=\"_blank\" rel=\"noreferrer noopener\">27779249<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tDr\u00f6gem\u00f6ller BI, Monzon JG, Bhavsar AP, Borrie AE, Brooks B, Wright GEB, Liu G, Renouf DJ, Kollmannsberger CK, Bedard PL, Aminkeng F, Amstutz U, Hildebrand CA, Gunaretnam EP, Critchley C, Chen Z, Brunham LR, Hayden MR, Ross CJD, Gelmon KA, Carleton BC.\u00a0<strong>Association between SLC16A5 genetic variation and cisplatin-induced ototoxic effects in adult patients with testicular cancer<\/strong>. JAMA Oncol. 2017 Nov 1;3(11):1558-1562. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28448657\/\" target=\"_blank\" rel=\"noreferrer noopener\">28448657<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Nouri MR, Sodhi M, Carleton BC.\u00a0<strong>Dentists\u2019 Prescribing of Analgesics for Children in British Columbia, Canada<\/strong>. J Can Dent Assoc. 2017 Aug;83:h5. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29360020\/\" target=\"_blank\" rel=\"noreferrer noopener\">29360020<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Nouri MR, Sodhi M, Carleton BC.\u00a0<strong>The Oral Health of Preschool Children of Refugee and Immigrant Families in Manitoba<\/strong>. J Can Dent Assoc. 2017 Aug;83(5). PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29106352\/\" target=\"_blank\" rel=\"noreferrer noopener\">29360020<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tSodhi M, Sheldon CA, Carleton B, Etminan M.\u00a0<strong>Oral Fluoroquinolones and Risk of Secondary Pseudotumor Cerebri Syndrome: A Nested Case-Control Study<\/strong>. Neurology. 2017 Aug 22;89(8):792-795. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28754842\/\" target=\"_blank\" rel=\"noreferrer noopener\">28754842<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tCheng JZ, Sodhi M, Etminan M, Carleton BC.\u00a0<strong>Fluoroquinolone Use and Risk of Carpal Tunnel Syndrome: A Pharmacoepidemiologic Study<\/strong>. Clin Infect Dis. 2017 Aug 15;65(4):684-686. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28444196\/\" target=\"_blank\" rel=\"noreferrer noopener\">28444196<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tFarzan N, Vijverberg SJ, Andiappan AK, Arianto L, Berce V, Blanca-L\u00f3pez N, Bisgaard H, B\u00f8nnelykke K, Burchard EG, Campo P, Canino G, Carleton B, Celed\u00f3n JC, Chew FT, Chiang WC, Cloutier MM, Daley D, Den Dekker HT, Dijk FN, Duijts , Flores C, Forno E, Hawcutt DB, Hernandez-Pacheco N, de Jongste JC, Kabesch M, Koppelman GH, Manolopoulos VG, Mel\u00e9n E, Mukhopadhyay S, Nilsson S, Palmer CN, Pino-Yanes M, Pirmohamed M, Poto\u010dnik U, Raaijmakers J, Repnik K, Schieck M, Sio YY, Smyth RL, Szalai C, Tantisira KG, Turner S, van der Schee MP, Verhamme KM, Maitland-van der Zee AH.\u00a0<strong>Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium<\/strong>. Pharmacogenomics. 2017 Jul;18(10):931-943. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28639505\/\" target=\"_blank\" rel=\"noreferrer noopener\">28639505<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tHorvath GA, Meisner L, Selby K, Stowe R, Carleton B.\u00a0<strong>Improved strength on 5-hydroxytryptophan and carbidopa in spinal cord atrophy<\/strong>. J Neurol Sci. 2017 Jul;15;378:59-62. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28566180\/\" target=\"_blank\" rel=\"noreferrer noopener\">28566180<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tKowalec K, Kingwell E, Carruthers R, Marrie RA, Bernatsky S, Traboulsee A, Ross CJD, Carleton BC, Tremlett H.\u00a0<strong>Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopenia<\/strong>. BMJ Open 2017 Jun 2;7(5):e016276. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28576902\/\" target=\"_blank\" rel=\"noreferrer noopener\">28576902<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tAminkeng F, Ross CJD, Rassekh SR, Rieder MJ, Bhavsar AP, Sanatani S, Bernstein D, Hayden MR, Amstutz U, Carleton BC.\u00a0<strong>Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer<\/strong>. Br J Clin Pharmacol. 2017 May;83(5):1143-1145. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28317142\/\" target=\"_blank\" rel=\"noreferrer noopener\">28317142<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tBhavsar AP, Gunaretnam EP, Li Y, Hasbullah JS, Carleton BC, Ross CJ.\u00a0<strong>Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines<\/strong>. PLoS One. 2017 Apr 13;12(4):e0175711. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28406961\/\" target=\"_blank\" rel=\"noreferrer noopener\">28406961<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tBardal S, Smith A, Luo HA, Zhang T, Groeneweg G, Jimenez Mendez R, Goldman R, Carleton B.\u00a0<strong>Asthma in British Columbia: Are We Finally Breathing Easier? A population-based study of the Burden of Disease Over 14 years<\/strong>. J Asthma. 2017 Apr;4(3):308-317 PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27414432\/\" target=\"_blank\" rel=\"noreferrer noopener\">27414432<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tSmith N, Smith A, Wang A, Shaw K, Groeneweg G, Goldman R, Wilkinson B, Jimenez R, Mwai L, Carleton B.\u00a0<strong>Physician and parent barriers to the use of oral corticosteroids for the prevention of pediatric URTI-induced acute asthma exacerbations at home<\/strong>. Pediatr Child Health. 2017 Jul;22(4):190-194. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29479212\/\" target=\"_blank\" rel=\"noreferrer noopener\">29479212<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEadie BD, Etminan M, Carleton BC, Maberley DA, Mikelberg FS.\u00a0<strong>Association of Repeated Intravitreous Bevacizumab Injections with Risk for Glaucoma Surgery<\/strong>. JAMA Ophthalmol. 2017 Apr 1;135(4):363-368. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28301639\/\" target=\"_blank\" rel=\"noreferrer noopener\">28301639<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tMcMahon KR, Rassekh SR, Schultz KR, Pinsk M, Blydt-Hansen T, Mammen C, Tsuyuki RT, Devarajan P, Cuvelier GD, Mitchell LG, Baruchel S, Palijan A, Carleton BC, Ross CJ, Zappitelli M, and Applying Biomarkers to Minimize Long-Term Effects of Childhood\/Adolescent Cancer Treatment (ABLE) Research Group.\u00a0<strong>Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood\/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study<\/strong>. \u00a0Can J Kidney Health Dis. 2017 Feb 16;4:1-13. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28270931\/\" target=\"_blank\" rel=\"noreferrer noopener\">28270931<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Sodhi M, Samii A, Procyshyn RM, Guo M, Carleton BC.\u00a0<strong>Risk of Gambling Disorders and Impulse Control Disorder with Aripiprazole Pramipexole and Ropinirole: A Pharmacoepidemiologic Study<\/strong>. J Clin Psychopharmacol. 2017 Feb;37(1):102-104. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27930495\/\" target=\"_blank\" rel=\"noreferrer noopener\">27930495<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Westerberg BD, Kozak FK, Guo MY, Carleton BC.\u00a0<strong>Risk of sensorineural hearing loss with macrolide antibiotics: A nested case-control study<\/strong>. Laryngoscope. 2017 Jan;127(1):229-232. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27497265\/\" target=\"_blank\" rel=\"noreferrer noopener\">27497265<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tDawes JM, Cooke EM, Hannam JA, Brand KA, Winton P, Jimenez-Mendez R, Aleksa K, Lauder GR, Carleton BC, Koren G, Rieder MJ, Anderson BJ, Montgomery CJ.\u00a0<strong>Oral morphine dosing predictions based on single dose in healthy children undergoing surgery<\/strong>. Paediatr Anaesth. 2017 Jan;27(1):28-36. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27779356\/\" target=\"_blank\" rel=\"noreferrer noopener\">27779356<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Procyshyn RM, Samii A, Carleton BC.\u00a0<strong>Risk of Extrapyramidal Adverse Events With Aripiprazole<\/strong>. J Clin Psychopharmacol. 2016 Oct;36(5):472-4. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27580493\/\" target=\"_blank\" rel=\"noreferrer noopener\">27580493<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tAminkeng F, Ross CJ, Rassekh SR, Hwang S, Rieder MJ, Bhavsar AP, Smith A, Sanatani S, Gelmon K, Bernstein D, Hayden MR, Amstutz U, Carleton BC, CPNDS Clinical Practice Recommendations Group.\u00a0<strong>Recommendations for Genetic Testing to Reduce the Incidence of Anthacycline-induced Cardiotoxicity<\/strong>. Br J Clin Pharmacol. 2016 Sep;82(3):683-95. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27197003\/\" target=\"_blank\" rel=\"noreferrer noopener\">27197003<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tLee JW, Pussegoda K, Rassekh RS, Monzon JG, Liu G, Hwang S, Bhavsar AP, Pritchard S, Ross CJ, Amstutz U, Carleton BC; CPNDS Clinical Practice Recommendations Group.\u00a0<strong>Clinical Practice Recommendations for the Management and Prevention of Cisplatin-induced Hearing Loss using Pharmacogenetic Markers<\/strong>. Ther Drug Monit. 2016 Aug;38(4):423-31. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26960170\/\" target=\"_blank\" rel=\"noreferrer noopener\">26960170\u00a0<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tMaagdenberg H, Vijverberg SJ, Bierings MB, Carleton BC, Arets HG, de Boer A, Maitland-van der Zee AH.\u00a0<strong>Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine<\/strong>. Paediatr Drugs. 2016 Aug;18(4):251-60. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27142473\/\" target=\"_blank\" rel=\"noreferrer noopener\">27142473<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tSmy L, Shaw K, Amstutz U, Smith A, Berger H, Carleton B, Koren G.\u00a0<strong>Hair cortisol as a hypothalamic-pituitary-adrenal axis biomarker in pregnant women with asthma: a retrospective observational study<\/strong>. BMC Pregnancy Childbirth. 2016 Jul 20;16(1):176. PMID\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27440139\/\" target=\"_blank\" rel=\"noreferrer noopener\">27440139\u00a0<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tTorosyan Y, Hu Y, Hoffman S, Lou Q, Carleton B, Marinac-Dabic D.\u00a0<strong>An In Silico Framework for Integrating Epidemiologic and Genetic Evidence with Health Care Applications: Ventilation-Related Pneumothorax as a Case Illustration<\/strong>. J Am Inform Med Assoc. 2016 Jul;23(4):711-20. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27107435\/\" target=\"_blank\" rel=\"noreferrer noopener\">27107435<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Maberley DA, Babiuk DW, Carleton BC.\u00a0<strong>Risk of Myocardial Infarction and Stroke with Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration<\/strong>. Am J Ophthalmol. 2016 Mar;163:53-8. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26701272\/\" target=\"_blank\" rel=\"noreferrer noopener\">26701272<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tChan SL, Samaranayake N, Ross CJ, Toh MT, Carleton B, Hayden MR, Teo YY, Dissanayake VH, Brunham LR.\u00a0<strong>Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: Implications for clinical implementation of pharmacogenomics<\/strong>. Pharmacogenet Genomics. 2016 Jan;26(1):28-39. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26444257\/\" target=\"_blank\" rel=\"noreferrer noopener\">26444257<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tSyme R, Carleton B, Leyens L, Richer E.\u00a0<strong>Integrating Personalized Medicine in the Canadian Environment: Efforts Facilitating Oncology Clinical Research<\/strong>. Public Health Genomics. 2015 Nov:18(6):372-80 PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26565702\/\" target=\"_blank\" rel=\"noreferrer noopener\">26565702<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tBaber M, Chaudhry S, Kelly L, Ross C, Carleton B, Berger H, Koren G.\u00a0<strong>The pharmacogenetics of codeine pain relief in the postpartum period<\/strong>. Pharmacogenomics J. 2015 Oct;15(5):430-5. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25752520\/\" target=\"_blank\" rel=\"noreferrer noopener\">25752520<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tAminkeng F, Bhavsar A, Visscher H, Rassekh SR, Li Y, Lee JW, Brunham LR, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Rieder MJ, Bernstein D, Ross CJ, Carleton BC, Hayden MR, and The Canadian Pharmacogenomics Network for Drug Safety Consortium.\u00a0<strong>A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer<\/strong>. Nat Genet. 2015 Sep;47(9):1079-84. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26237429\/\" target=\"_blank\" rel=\"noreferrer noopener\">26237429<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Carleton B, Brophy JM.\u00a0<strong>Risperidone and risk of gynecomastia in young men<\/strong>. J Child Adolesc Psychopharmacol. 2015 Nov. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26287371\/\" target=\"_blank\" rel=\"noreferrer noopener\">26287371<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tJimenez R, Smith A, Carleton B.\u00a0<strong>New ways of detecting ADRs in neonates and children<\/strong>. Curr Pharm Des. 2015;21(39):5643-9. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26323415\/\" target=\"_blank\" rel=\"noreferrer noopener\">26323415<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tShaw K, Amstutz U, Kim R, Lesko LJ, Rhoades J, Turgeon J, Michaud V, Hwang S, Ito S, Carleton BC and the CPNDS clinical recommendations group.\u00a0<strong>Clinical practice recommendations on genetic testing of CYP2C9 and VKORC1 variants in wafarin therapy<\/strong>. Ther Drug Monitoring. 2015 Aug;37(4):428-36. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26186657\/\" target=\"_blank\" rel=\"noreferrer noopener\">26186657<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tVisscher H, Rassekh SR, Sandor GS, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Rogers PC, Rieder MJ, Carleton BC, Hayden MR, Ross CJ, &amp; the CPNDS consortium.\u00a0<strong>Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children<\/strong>. Pharmacogenomics. 2015 Jul;16(10):1065-76. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26230641\/\" target=\"_blank\" rel=\"noreferrer noopener\">26230641<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tBuxton JA, Omura J, Kuo M, Ross C, Tzemis D, Purssell R, Gardy J, Carleton B.\u00a0<strong>Genetic determinants of cocaine-associated agranulocytosis<\/strong>. BMC Res Notes 2015 Jun;13;8:240. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26070312\/\" target=\"_blank\" rel=\"noreferrer noopener\">26070312<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tSmolina K, Weymann D, Morgan S. Ross C. Carleton B.\u00a0<strong>Association between regulatory advisories and codeine prescribing to postpartum women<\/strong>. JAMA. 2015 May;313(18):1861-2. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25965237\/\" target=\"_blank\" rel=\"noreferrer noopener\">25965237<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tSmy L, Shaw K, Smith A, Russell E, Van Uum S, Rieder M, Carleton B, Koren G.\u00a0<strong>Hair cortisol as a novel biomarker of HPA suppression by inhaled corticosteroids in children<\/strong>. Pediatr Res. 2015 Jul;78(1):44-7. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25790275\/\" target=\"_blank\" rel=\"noreferrer noopener\">25790275<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tVelez de Mendizabal N, Jimenez-Mendez R, Cooke E, Montgomery C, Dawes J, Jacobo-Cabral CO, Gonzalez-Ramirez R, Castaneda-Hernandez G, Carleton BC.\u00a0<strong>A compartmental analysis for morphine and its metabolites in young children after a single oral dose<\/strong>. Clin Pharmacokinet. 2015 Oct;54(10):1083-90. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25773480\/\" target=\"_blank\" rel=\"noreferrer noopener\">25773480<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tAlmonte M, Velasquez-Jones L, Valverde S, Carleton B, Medeiros M.\u00a0<strong>Post-renal transplant erythocytosis: A case report<\/strong>. Pediatr Transplant. 2015 Feb;19(1):E7-E10. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25418869\/\" target=\"_blank\" rel=\"noreferrer noopener\">25418869<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tMedeiros M, Casta\u00f1eda-Hern\u00e1ndez G, Ross CJ, Carleton BC.\u00a0<strong>Use of pharmacogenomics in pediatric renal transplant recipients<\/strong>. Front Genet. 2015 Feb18;6:41. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25741362\/\" target=\"_blank\" rel=\"noreferrer noopener\">25741362<\/a><\/li>\n<li\n\t class=\"fndry-list-item\">\n\tEtminan M, Skeldon SC, Goldenberg SL, Carleton B, Brophy JM.\u00a0<strong>Testosterone therapy and risk of myocardial Infarction: a pharmacoepidemiologic study<\/strong>. Pharmacotherapy. 2015 Jan;35(1):72-8. PMID:\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25582846\/\" target=\"_blank\" rel=\"noreferrer noopener\">25582846<\/a><\/li>\n<\/ul><\/div>\n<\/div><\/div>\n\n\n<div  class=\"fndry-container fndry-responsive-bg fndry-responsive-border\">\n\t<div class=\"fndry-row fndry-justify--sm-center fndry-justify--between fndry-flex--row\">\n\t<div  class=\"fndry-col fndry-responsive-bg fndry-col--12 fndry-col--md-10 fndry-col--sm-12 fndry-pl--2 fndry-pb--5 fndry-pt--5 fndry-pt--md-2 fndry-pb--md-2 fndry-d--flex fndry-justify--between\">\n\t<a  href=\"https:\/\/www.bcchr.ca\/popi\/research-capabilities\/\" rel=\"\" id=\"fndry-block-64b55330e7323\" class=\"fndry-btn fndry-btn-secondaryButtonWLeftArrow\">Research Capabilities<\/a><a  href=\"https:\/\/www.bcchr.ca\/popi\/links\/\" rel=\"\" id=\"fndry-block-64b55330e7323\" class=\"fndry-btn fndry-btn-secondaryButtonWArrow\">Links<\/a><\/div>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":8,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_lmt_disableupdate":"","_lmt_disable":"","inline_featured_image":false,"footnotes":"","fndry_alternate_title":"Alternate Title!"},"class_list":["post-1215","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.bcchr.ca\/popi\/wp-json\/wp\/v2\/pages\/1215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bcchr.ca\/popi\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bcchr.ca\/popi\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bcchr.ca\/popi\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bcchr.ca\/popi\/wp-json\/wp\/v2\/comments?post=1215"}],"version-history":[{"count":7,"href":"https:\/\/www.bcchr.ca\/popi\/wp-json\/wp\/v2\/pages\/1215\/revisions"}],"predecessor-version":[{"id":2882,"href":"https:\/\/www.bcchr.ca\/popi\/wp-json\/wp\/v2\/pages\/1215\/revisions\/2882"}],"wp:attachment":[{"href":"https:\/\/www.bcchr.ca\/popi\/wp-json\/wp\/v2\/media?parent=1215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}